Oyeyemi Elizabeth
New member
THE U.S–AFRICA HEALTH AID DEAL YOU’RE NOT SUPPOSED TO KNOW
—By Moreblessing Dr. Crypto
I find the terms extremely disturbing and concerning.
Number 3 is even more scary.
The Ghanaian President, John Mahama last week revealed In a discussion at the Washington-based Council on Foreign Relations, why his government rejected the proposed U.S. health compact after it was reviewed by Ghana’s Ministry of Health and Cabinet.
It was a health aid deal.
According to Mahama, the proposed agreement was worth approximately $109 million over five years, but came with conditions that Ghana considered unacceptable.
Here are some of the terms he publicly identified:
1. PATHOGEN PROFILE
According to President Mahama, Ghana was required to provide the United States with its “pathogen profile.”
What does that mean?
In simple terms, a country’s pathogen profile concerns the diseases and disease-causing organisms circulating within its population and environment.
This can include information about:
• Diseases endemic to the country
• Infectious organisms circulating within the population
• Disease patterns and prevalence
• Epidemiological information
• Potential biological threats and vulnerabilities
This isn’t ordinary administrative data.
Public-health data can have strategic value.
Knowing what pathogens circulate in a country can help researchers understand disease risks, monitor outbreaks and develop treatments and vaccines.
That can obviously have legitimate public-health benefits when countries share information responsibly.
But the concern is who controls the data?
What does the US government need such data of another country for?
Those questions become even more important when the information involves an entire nation’s biological and epidemiological record.
2. MEDICAL RECORDS
This one is even more sensitive.
President Mahama said the proposed compact/terms also required Ghana to provide medical records.
Think about what exists inside a medical record.
Your:
• Diagnoses
• Treatments
• Medication history
• Laboratory results
• Medical procedures
• HIV and infectious-disease status
• Genetic and biological information
• Reproductive health information
• Mental-health information
• Other highly sensitive personal health data
Medical information isn’t just another government dataset.
It can reveal extremely intimate details about millions of people.
And once sensitive health information leaves the country, the critical questions become:
Who now owns it?
Who can access it?
Where is it stored?
What is it being used for?
Can it be transferred to researchers, companies, contractors or other governments?
Can it be used for purposes beyond the original health programme?
What happens if the database is hacked or leaked?
These are legitimate data-governance questions—not conspiracy theories.
President Mahama himself questioned why one country would be required to provide another country with its citizens’ medical records and said this was one of the provisions Ghana rejected. (Council on Foreign Relations)
And this is happening at a time when health data is becoming one of the most valuable categories of data in the world, particularly as AI, biotechnology, genomics and pharmaceutical research become increasingly data-driven.
3. NO INSPECTION OF MEDICAL PRODUCTS
This is the one that bother me the most.
According to President Mahama, the proposed compact stipulated that medications and other medical products brought into the country under the programme would not be subject to inspection by Ghana’s Food and Drugs Authority (FDA).
Think of Ghana’s FDA as your NAFDAC, SON e.t.c
Think about what that means.
A deal that outrightly seeks to render your food and drug agencies whose primary goal is to ensure everything that’s been produced, imported, sold and consumed within the country is standardized and safe for consumption useless.
NAFDAC will have “absolutely no right to inspect” those imports.
We’re just supposed to TRUST the United States Gov’t, collect the money and start consuming whatever health supplies including vaccines, drugs, injections e.t.c that will be imported.
A complete takeover of regulatory sovereignty of another country, just for a health aid”
Prohibited from checking the quality, safety, or suitability of those goods and health supplies entering the country under the deal.
The deal seeks to bypass the country’s regulatory inspection process.
That creates a very serious sovereignty question:
Who ultimately has the authority to determine whether a medical product is safe for the population?
The country’s own regulator?
Or a foreign government whose primary interest is definitely not you.
When it comes to medicines, vaccines, injections and other health products, mistakes can have consequences far beyond financial losses.
And according to Mahama, the proposed compact would have restricted Ghana’s food and drug agency from exercising their regulatory oversight authority over products supplied under the programme.
“HELPING” A COUNTRY WHILE DEMANDING ACCESS TO ITS MOST SENSITIVE MEDICAL DATA AND REMOVING ITS REGULATORY AUTHORITY OVER IMPORTED HEALTH PRODUCTS/SUPPLIES.
This was offered to over a dozen African countries.
Add-on: Countries offered similar deal includes: South Africa, Nigeria, Zambia, Uganda, Namibia, Kenya e.t.c (Full list in the comments section)
Ghana rejected the offer, your country signed it.
—Dr. Crypto
—By Moreblessing Dr. Crypto
I find the terms extremely disturbing and concerning.
Number 3 is even more scary.
The Ghanaian President, John Mahama last week revealed In a discussion at the Washington-based Council on Foreign Relations, why his government rejected the proposed U.S. health compact after it was reviewed by Ghana’s Ministry of Health and Cabinet.
It was a health aid deal.
According to Mahama, the proposed agreement was worth approximately $109 million over five years, but came with conditions that Ghana considered unacceptable.
Here are some of the terms he publicly identified:
1. PATHOGEN PROFILE
According to President Mahama, Ghana was required to provide the United States with its “pathogen profile.”
What does that mean?
In simple terms, a country’s pathogen profile concerns the diseases and disease-causing organisms circulating within its population and environment.
This can include information about:
• Diseases endemic to the country
• Infectious organisms circulating within the population
• Disease patterns and prevalence
• Epidemiological information
• Potential biological threats and vulnerabilities
This isn’t ordinary administrative data.
Public-health data can have strategic value.
Knowing what pathogens circulate in a country can help researchers understand disease risks, monitor outbreaks and develop treatments and vaccines.
That can obviously have legitimate public-health benefits when countries share information responsibly.
But the concern is who controls the data?
What does the US government need such data of another country for?
Those questions become even more important when the information involves an entire nation’s biological and epidemiological record.
2. MEDICAL RECORDS
This one is even more sensitive.
President Mahama said the proposed compact/terms also required Ghana to provide medical records.
Think about what exists inside a medical record.
Your:
• Diagnoses
• Treatments
• Medication history
• Laboratory results
• Medical procedures
• HIV and infectious-disease status
• Genetic and biological information
• Reproductive health information
• Mental-health information
• Other highly sensitive personal health data
Medical information isn’t just another government dataset.
It can reveal extremely intimate details about millions of people.
And once sensitive health information leaves the country, the critical questions become:
Who now owns it?
Who can access it?
Where is it stored?
What is it being used for?
Can it be transferred to researchers, companies, contractors or other governments?
Can it be used for purposes beyond the original health programme?
What happens if the database is hacked or leaked?
These are legitimate data-governance questions—not conspiracy theories.
President Mahama himself questioned why one country would be required to provide another country with its citizens’ medical records and said this was one of the provisions Ghana rejected. (Council on Foreign Relations)
And this is happening at a time when health data is becoming one of the most valuable categories of data in the world, particularly as AI, biotechnology, genomics and pharmaceutical research become increasingly data-driven.
3. NO INSPECTION OF MEDICAL PRODUCTS
This is the one that bother me the most.
According to President Mahama, the proposed compact stipulated that medications and other medical products brought into the country under the programme would not be subject to inspection by Ghana’s Food and Drugs Authority (FDA).
Think of Ghana’s FDA as your NAFDAC, SON e.t.c
Think about what that means.
A deal that outrightly seeks to render your food and drug agencies whose primary goal is to ensure everything that’s been produced, imported, sold and consumed within the country is standardized and safe for consumption useless.
NAFDAC will have “absolutely no right to inspect” those imports.
We’re just supposed to TRUST the United States Gov’t, collect the money and start consuming whatever health supplies including vaccines, drugs, injections e.t.c that will be imported.
A complete takeover of regulatory sovereignty of another country, just for a health aid”
Prohibited from checking the quality, safety, or suitability of those goods and health supplies entering the country under the deal.
The deal seeks to bypass the country’s regulatory inspection process.
That creates a very serious sovereignty question:
Who ultimately has the authority to determine whether a medical product is safe for the population?
The country’s own regulator?
Or a foreign government whose primary interest is definitely not you.
When it comes to medicines, vaccines, injections and other health products, mistakes can have consequences far beyond financial losses.
And according to Mahama, the proposed compact would have restricted Ghana’s food and drug agency from exercising their regulatory oversight authority over products supplied under the programme.
“HELPING” A COUNTRY WHILE DEMANDING ACCESS TO ITS MOST SENSITIVE MEDICAL DATA AND REMOVING ITS REGULATORY AUTHORITY OVER IMPORTED HEALTH PRODUCTS/SUPPLIES.
This was offered to over a dozen African countries.
Add-on: Countries offered similar deal includes: South Africa, Nigeria, Zambia, Uganda, Namibia, Kenya e.t.c (Full list in the comments section)
Ghana rejected the offer, your country signed it.
—Dr. Crypto